"Whats your point?" and "Why do you care?" The

New Post Public Reply Private Reply Replies (0) Message Board
Pugilista

"Whats your point?"
and
"Why do you care?"

The two best questions to ask a naysayer.

Think about it..

Naysayers post reasons why Rmhb is a 'bad' investment right?
Reason after reason after reason.

But their posts shouldn't end there. Shouldn't their posts include their intentions behind their reasons? In other words, "Whats the point of them constantly posting?"

Looking at it like this makes their posts funny, ridiculous, obviously agenda-driven, and irrelevant. Their negative posts have NO reasons behind them. Are they posting to 'help' us? No. They never said they were, right? And yet, day after day they post negative comments about Rmhb yet continually 'forget' to include 'why' theyre posting in the first place.

No one spends countless hours pointing out the negative aspects of a company unless there is something in it for themselves. Because, think about it this way..

If they are true investors who want to make money in a company, wouldn't they want to PROMOTE the company by only posting positive posts? See how ridiculous they are? By posting negative comments, they reveal their agenda without even having to say it. Their agenda is to keep the price down at the expense of you, me, our money, our investments, and at the risk of us losing our investment. Simple as that.
(0) (0)



There is a VERY HIGH degree of RISK involved in trading and INVESTING. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and INVESTING. Only invest what you can afford to lose.

Rocky Mountain High Brands, Inc. (RMHB) Stock Research Links

RMHB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AULUMU Unveils High-Design ADuo iPhone Case

Updated Category News Views 7

A Space-Aged Look for Everyday Use In the gadget world, appearances matter but durability matters more. So AULUMU rolls out the ADuo Particle Aramid Fiber Case for iPhone Duo, making a bold claim in the realm of tech accessories. The Backbone: Aramid Fiber Aramid fiber isn't your run-of-the-mill material. We're talking 1500D quality here—strong but feather-light, a...

Continue Reading
Qatar's Cultural Ventures Go Big Through 2030

Updated Category News Views 2

Cultural Partners Lined Up Well Ahead In the swirling world of cultural diplomacy, Qatar's got its eyes set way beyond the skyline with their Years of Culture initiative. Announced recently, they've lined up partners through 2030, locking hands with Italy, the Netherlands, Switzerland, Portugal, and Spain in the coming years. Such moves aren't just for show—they’re...

Continue Reading
TORL Bio's Ixo-V Drug Shows Promise in Combatting GCT

Updated Category News Views 4

A Beacon of Hope in Germ Cell Tumor Treatment There's something brewing in the oncology world that's worth a nod. TORL BioTherapeutics has rolled out some interesting preliminary data for their hopeful cancer buster, ixotatug vedotin, or Ixo-V. This study is part of a wider effort to take a swing at recurrent germ cell tumors (GCTs) with some tough results already making...

Continue Reading
GoDaddy Launches 'Ink Your Link' in NYC

Updated Category News Views 5

GoDaddy's Bold Stunt at the Big Apple In the noise of the New York Stock Exchange, everyone is abuzz with GoDaddy’s latest marketing push. Aptly titled 'Ink Your Link,' this campaign has NYC in its sights this weekend, targeting entrepreneurs and consumers alike. The plan is to open a unique pop-up in Manhattan where business owners can ink a temporary tattoo—a bold...

Continue Reading
SOCaaS Market Grows to $16.68B by 2031, What It Means

Updated Category News Views 9

SOC as a Service: More Than Just Jargon The term 'SOC as a Service' (SOCaaS) might sound like some alphabet soup, but it’s a serious contender in today’s digital security world. With projected growth from $9.04 billion in 2026 to a whopping $16.68 billion by 2031, the SOCaaS market isn’t just having a moment, it’s setting up a stage for the long haul. It’s like...

Continue Reading
Hyperliquid Expands Stock Buyback to $100 Million

Updated Category News Views 0

Diving Into Hyperliquid's $100 Million Bold Move Let’s cut through the corporate fluff—Hyperliquid Strategies Inc. just cranked up their stock repurchase program to a cool $100 million. Yep, that’s right—the brain trust behind NASDAQ:PURR has pulled out the checkbook to buy more of its own shares. This decision, unveiled on October 23, 2026, is like tossing a...

Continue Reading
Autoliv Sees Mixed Q3 2026 Amid Global Challenges

Updated Category News Views 4

An Uneven Road: Autoliv's Q3 2026 Chronicle You'd think by now everyone in the automotive game would have mastered the art of the pivot. Well, Autoliv seems to have gotten the memo for Q3 2026. Sales dipped slightly, yet their moves in Asia hint at a calculated gambit in a rough global landscape. Digging into the Numbers The financials were a mixed bag. Net sales huddled...

Continue Reading
Tragedy in Jordan: A Call for Unity and Support

Updated Category News Views 0

A Dark Day in Jordan It's a gut punch, hearing news of yet another brutal attack targeting the Christian community in Jordan's Karak province. This act of terror isn't just a regional dagger—it cuts deep into the fabric of shared humanity. On Friday, the tranquil air of a sacred gathering was shattered, leaving behind grief and a call to action for those who refuse to...

Continue Reading
Ractigen's LiCO™ Platform Hits Extrahepatic Milestones

Updated Category News Views 5

Breaking New Ground in RNA Therapeutics Hey, in the world of biotech, landing a meaningful delivery system is like striking gold, and it seems Ractigen Therapeutics just found a shiny nugget. Their latest study on the LiCO™ platform, living and breathing in the pages of Molecular Therapy - Nucleic Acids, maps out a path to some serious therapeutic territory. These guys...

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 4

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Blackbaud's Short Interest Trends and Market Sentiment

Updated Category News Views 254

Understanding Blackbaud's Short Interest Dynamics Blackbaud's short interest, which refers to stocks that are sold short but not yet repurchased, has seen a notable decrease of 6.58% according to the latest report. This decline is intriguing given its critical role in investment strategies. Currently, the company has 613,000 shares sold short, making up approximately...

Continue Reading
ECARX Reports Strong Financial Performance for 2024

Updated Category News Views 180

ECARX Holdings Inc. Overview ECARX Holdings Inc. (NASDAQ: ECX), a pioneering global mobility technology provider, recently published its unaudited financial results for 2024. The year marked a remarkable journey for the company, demonstrating considerable growth and strategic advancement in the automotive technology sector. Highlights of 2024 Financial Performance Strong...

Continue Reading
Emerging Cancer Treatment Innovations Transform Patient Care

Updated Category News Views 282

Innovative Approaches in Cancer Treatment The landscape of cancer treatment is rapidly evolving, with breakthroughs that are reshaping how we approach various forms of this complex disease. Major pharmaceutical companies are making waves with new survival data and innovative lung cancer treatments that leverage distinct mechanisms. These advancements represent a shift in...

Continue Reading
Peter Schiff Raises Concerns Over MicroStrategy's Debt Moves

Updated Category News Views 285

Peter Schiff Questions MicroStrategy's Financial Strategy Economist and market analyst Peter Schiff recently expressed doubts regarding MicroStrategy Inc’s MSTR approach to convertible debt offerings. His comments raise alarms about possible financial instability, especially for companies heavily invested in Bitcoin. Recent Market Behavior Despite a 2.5% rise in...

Continue Reading
Strategic Expansion: Harbor Group International's Latest Acquisition

Updated Category News Views 235

Harbor Group International's Commitment to Growth Harbor Group International, LLC (HGI), a dedicated real estate investment and management firm, has made a significant move in their strategy by acquiring Reflections, a multifaceted community that adds substantial value to their existing portfolio. A Strategic Acquisition HGI has successfully completed an acquisition...

Continue Reading